Residency · Muncie, IN
Sponsored by Indiana University School of Medicine
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
The New England journal of medicine · 2021 · 889 citations · Pooja Singal
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study.
The Lancet. Oncology · 2024 · 102 citations · Maitri Kalra
Comprehensive review of surgical microscopes: technology development and medical applications.
Journal of biomedical optics · 2021 · 94 citations · Ling Ma
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2).
Nature communications · 2021 · 185 citations · Ling Ma
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.
The Lancet. Oncology · 2022 · 136 citations · Ling Ma
Cardiovascular Magnetic Resonance Reference Ranges From the Healthy Hearts Consortium.
JACC. Cardiovascular imaging · 2024 · 39 citations · Ahmed Al Qady
Performance and attitudes toward real-time computer-aided polyp detection during colonoscopy in a large tertiary referral center in the United States.
Gastrointestinal endoscopy · 2023 · 59 citations · Fredy Nehme
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.
Journal for immunotherapy of cancer · 2023 · 49 citations · Paul Walker